The Wall Street Journal
@WSJ
Sign up for our newsletters and alerts: | Got a tip? | For WSJ customer support:
Joined April 2007
1.1K Following 22.2M Followers
Novo Nordisk agreed to license and develop the technology, which could cut the frequency patients need to inject its obesity and diabetes drugs.
